Literature DB >> 3140453

Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation.

G Winde1, K H Dietl, H Raidt, B Buchholz, A E Lison, H Bünte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3140453

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Muromonab CD3. A review of its pharmacology and therapeutic potential.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

2.  Cytomegalovirus infection as a complication of OKT3 therapy in kidney transplant recipients.

Authors:  P J Conlon; M Carmody; J Donohoe; S Spencer; E Smyth; J J Walshe
Journal:  Ir J Med Sci       Date:  1992-11       Impact factor: 1.568

3.  OKT3 prophylaxis in liver transplantation.

Authors:  S V McDiarmid; M J Millis; P I Terasaki; M E Ament; R W Busuttil
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.